74 results
8-K
EX-10.1
INMB
INmune Bio Inc
13 Jun 24
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.2
INMB
INmune Bio Inc
16 May 24
Departure of Directors or Certain Officers
4:00pm
8-K
EX-10.1
INMB
INmune Bio Inc
16 May 24
Departure of Directors or Certain Officers
4:00pm
8-K
EX-10.2
INMB
INmune Bio Inc
26 Apr 24
INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:28pm
8-K
EX-10.1
INMB
INmune Bio Inc
26 Apr 24
INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:28pm
8-K
EX-10.3
c03iom 2n57
22 Apr 24
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-10.1
7fd169148h
22 Apr 24
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-10.2
kr0m6tr
22 Apr 24
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-10.1
4afyes5z 634bgsh7256
1 Jun 23
Departure of Directors or Certain Officers
4:00pm
8-K
EX-10.1
tika5t6vkf9zu
20 Apr 23
XPro1595 Improves Outcomes in a Mouse Model of TBI-induced Alzheimer’s Disease
4:30pm
8-K
EX-10.2
rek8tfv0fi0t2
20 Apr 23
XPro1595 Improves Outcomes in a Mouse Model of TBI-induced Alzheimer’s Disease
4:30pm
8-K
EX-10.2
gf9h8gp qziq9y
24 Mar 22
Departure of Directors or Certain Officers
4:01pm
8-K
EX-10.1
4man6a 78pa
24 Mar 22
Departure of Directors or Certain Officers
4:01pm
8-K
EX-10.1
i1cf56w36o o9
24 Mar 22
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-10.1
lf7q57uqam4t8idop
15 Sep 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
dtmm16j4
15 Jul 21
Inmune Bio, Inc. Announces $40 Million
4:41pm
8-K
EX-10.2
q8mz mczqb
15 Jul 21
Inmune Bio, Inc. Announces $40 Million
4:41pm
8-K
EX-10.2
w4widrci03nz55
24 Jun 21
Departure of Directors or Certain Officers
4:40pm
8-K
EX-10.1
g6o1vnv
24 Jun 21
Departure of Directors or Certain Officers
4:40pm
8-K
EX-10.5
yuvgt
15 Jun 21
INmune Bio, Inc. Announces $15 Million Credit Facility to Purchase Xencor Option to Reduce Future Dilution
4:03pm